dc.contributor.author
Soleimani, Khadijeh
dc.contributor.author
Beyranvand, Siamak
dc.contributor.author
Souri, Zeinab
dc.contributor.author
Ahmadian, Zainab
dc.contributor.author
Yari, Abdollah
dc.contributor.author
Faghani, Abbas
dc.contributor.author
Shams, Azim
dc.contributor.author
Adeli, Mohsen
dc.date.accessioned
2023-11-06T13:02:49Z
dc.date.available
2023-11-06T13:02:49Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/41448
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-41170
dc.description.abstract
A supramolecular redox responsive nanogel (NG) with the ability to sense cancer cells and loaded with a releasing therapeutic agent was synthesized using hostguest interactions between polyethylene glycol-grafted-β-cyclodextrin and ferrocene boronic acid. Cyclic voltammetry matched with other spectroscopy and microscopy methods provided strong indications regarding host-guest interactions and formation of the NG. Moreover, the biological properties of the NG were evaluated using fluorescence silencing, confocal laser scanning microscopy, and cell toxicity assays. Nanogel with spherical core-shell architecture and 100–200 nm sized nanoparticles showed high encapsulation efficiency for doxorubicin (DOX) and luminol (LU) as therapeutic and sensing agents. High therapeutic and sensing efficiencies were manifested by complete release of DOX and dramatic quenching of LU fluorescence triggered by 0.05 mM H2O2 (as an ROS component). The NGs showed high ROS sensitivity. Taking advantage of a high loading capacity, redox sensitivity, and biocompatibility, the NGs can be used as strong theranostic systems in inflammation-associated diseases.
en
dc.format.extent
10 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
Redox responsive
en
dc.subject
Supramolecular
en
dc.subject
Theranostics
en
dc.subject.ddc
500 Naturwissenschaften und Mathematik::540 Chemie::540 Chemie und zugeordnete Wissenschaften
dc.title
Ferrocene/ β-cyclodextrin based supramolecular nanogels as theranostic systems
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
115402
dcterms.bibliographicCitation.doi
10.1016/j.biopha.2023.115402
dcterms.bibliographicCitation.journaltitle
Biomedicine & Pharmacotherapy
dcterms.bibliographicCitation.volume
166
dcterms.bibliographicCitation.url
https://doi.org/10.1016/j.biopha.2023.115402
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Chemie und Biochemie
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1950-6007
refubium.resourceType.provider
WoS-Alert